Twitter LinkedIn
    Thursday, August 18
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Fundraising»Arch Venture Partners raises $1.85bn for biggest fund yet, less than a year after closing $1.46bn predecessor
    Fundraising

    Arch Venture Partners raises $1.85bn for biggest fund yet, less than a year after closing $1.46bn predecessor

    February 4, 20212 Mins Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Biotech investment specialist Arch Venture Partners has hit a $1.85bn final close for its eleventh flagship fundraise, less than a year after hauling in almost $1.5bn for its predecessor vehicle.

    Arch said it would invest Fund XI in early stage biotech companies working in areas including infectious disease, mental health, immunology, oncology and neurology, as well as manufacturing, clinical trials, anti-aging medicines, genomic and biological tools.

    Fund XI is easily Arch’s largest fund to date. The firm raised $1.1bn across Fund IX and Fund IX Overage in 2016, and $560m across Fund VIII and Fund VIII Overage in 2014.

    Firm co-founder and managing director Robert Nelsen said, “From its start, ARCH sought out great science with the potential to significantly improve human health.

    “While Fund XI is our largest to date, we have always invested at levels that each company or technology needed to advance, whether it’s $50,000 or $250m.

    “We are continually proud to help bring together and advise scientists and entrepreneurs to create successful enterprises.”

    Managing director Kristina Burow added, “Particularly in the midst of the ongoing pandemic, companies that can bring cutting-edge medicines and tools forward are both clearly important and good investments.

    “Now more than ever, we have a sense of urgency and purpose to back companies that could meaningfully change medicine for the better.”

    Arch also revealed it had named venture partner Paul Berns as a managing director, and hired Jay Markowitz as a senior partner after more than 19 years analyzing, investing, and working in the biopharmaceutical industry.

    His experience includes nine years at T Rowe Price, seven years at Capital Group, and three years as a senior vice president at Regeneron Pharmaceuticals.

    Source: AltAssets

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Capital Fundraising funds PE Insider Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Saudi Arabia’s PIF, Cain invest $900m in hotelier Aman Group

    August 17, 2022

    Denham Capital to sell Nexif Energy’s portfolio to RATCH Group in deal worth $1B

    August 17, 2022

    Thompson Street Capital Partners closes sixth PE fund at over $1.5B in commitments

    August 17, 2022

    KKR acquires Barracuda from Thoma Bravo

    August 17, 2022

    Comments are closed.

    Other Articles

    MetLife Investment Management to provide GBP117.5m in financing for English Football League

    March 30, 2021

    KKR and Ontario Teachers’ Strengthen Commitment in India’s Road Sector

    April 21, 2022

    CVC and Greenbriar Announce Recapitalization of Radwell International

    April 4, 2022

    BlackRock tests Chinese retail appetite with mutual fund launch

    September 3, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?